RNAseq data for myeloid cell types collected at the onset of CRS revealed that IL-1R1 was up-regulated in tumor-associated myeloid cells, while only IL-1R2 was detected in spleen myeloid cells [9]. The gene discussed is IL1R1; the disease is neoplasm.